Why the study?
Do sotalol and dofetilide prevent AF induction and terminate AF in a vagotonic dog model?
Do sotalol and dofetilide prevent AF induction and terminate AF in a vagotonic dog model?
Sotalol and dofetilide prevent AF initiation by premature depolarizations at doses that fail to terminate vagotonic AF by increasing the effective refractory period beyond the associated conduction delay.
Answers are grounded in this paper and cite their sources.
May prevent AF induction by premature stimuli but not terminate vagotonic AF in dogs; leaves open human translation.
BACKGROUND: Clinical trials suggest that sotalol and dofetilide are much more effective in preventing atrial fibrillation (AF) than in terminating it. This study evaluated potential mechanisms of discordant sotalol and dofetilide effects on AF termination vs. prevention. METHODS: We applied 240-electrode epicardial mapping and programmed stimulation in a vagotonic dog model of AF before and after dofetilide or sotalol. RESULTS: Under control conditions, sustained AF could be induced by single S(2) extrastimuli that caused unidirectional block and macroreentry. Sotalol (2 mg/kg) and dofetilide (0.04 mg/kg) failed to terminate AF in any dog, but prevented AF induction by S(2) stimuli in 19/22 (86%) and 4/5 (80%) of animals, respectively. With sotalol and dofetilide, unidirectional block still occurred, but wavefront reentry failed. The prevention of S(2)-induced reentry was related to large increases in the effective refractory period (ERP) at a BCL of 1000 ms, leading to ERPs that exceeded the conduction delay following S(2). Reverse use-dependent effects resulted in smaller ERP increases at BCLs closer to the AF cycle length. Although the number of zones of reactivation per cycle during sustained AF were decreased by sotalol and dofetilide, the changes were small and insufficient to terminate AF. CONCLUSIONS: Sotalol and dofetilide prevent AF initiation by premature depolarizations at doses that fail to terminate vagotonic AF, by increasing ERP at the basic cycle length beyond the associated conduction delay that leads to reentry.
No takes yet. Share an insight, caveat, or question.
Katayoun Derakhchan (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: